Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Figlin RA et al. - The baseline status of the molecular markers PTEN and HIF1 alpha did not correlate with efficacy in renal cell carcinoma patients treated with temsirolimus versus IFN. Patients demonstrated OS and progression-free survival benefit when treated with temsirolimus regardless of PTEN and HIF1 alpha status.

Exclusive Author Commentary
Robert A. Figlin, 06/16/09

Although this study did not demonstrate a correlation with response and survival for the biomarkers tested, it remains a high priority for all trials in renal cell carcinoma to identify and test the validity of a biomarker to predict biologic behavior.

Today in Basic Science/Genetics...keeping you current

Conditionally immortalized human podocyte cell lines established from urine
American Journal of Physiology: Renal Physiology, 12/04/09

Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues
Journal of Cancer Research & Clinical Oncology, 12/04/09

Familiality of kidney stone disease in Iceland
Scandinavian Journal of Urology and Nephrology, 12/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address